Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
07/2003
07/30/2003CN1433318A Vascular endothelial growth factor-2
07/30/2003CN1433317A Use of immunosuppessant for increasing antifungal activity of lipopetide
07/30/2003CN1433314A Antimicrobial compositions and methods of use
07/30/2003CN1433313A Combination of serotonin reuptake inhibitor and 5-HT2C antagonist, inverse agonist or partial agonist
07/30/2003CN1432357A Fever allaying prepn containing xylitol
07/30/2003CN1116104C Method capable of scale preserving bioactivity matter by drying
07/30/2003CN1116076C Compisition for prevention and treatment of helminth infections
07/30/2003CA2369711A1 Macrocyclic peptides active against the hepatitis c virus
07/29/2003US6600013 Moraxella catarrhalis BASB034 polypeptides and uses thereof
07/29/2003US6600010 Biodegradable terephthalate polyester-poly (phosphate) polymers, compositions, articles, and methods for making and using the same
07/29/2003US6599938 Optionally substituted Schiff base condensation products comprising an amino acid component and a benzaldehyde component, that have MIF (macrophage migration inhibitory factor) antagonist activity
07/29/2003US6599923 Insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action
07/29/2003US6599912 Methods and compositions for modulating cell proliferation and cell death
07/29/2003US6599888 These combinations have shown a synergistic effect compared with compositions containing either glucosamine alone, or chondroitin sulfate alone
07/29/2003US6599876 Medicament and method for treating renal disease
07/29/2003US6599727 Human poly (ADP-ribose) polymerase 2 materials and methods
07/29/2003US6599695 Method for assaying for early gene expression in neuroblasts
07/29/2003US6599540 Use of a Serenoa repens extract for the production of a medicament to treat prostate cancer
07/29/2003US6599537 Antiradical, cytophotoprotective, tyrosinase and melanogenesis inhibiting and antiprotease effects
07/29/2003US6599532 Controlled release alprazolam in the core optionally in combination with an anti-psychotic agent, in a rapid release external coat; smaller, easier to swallow
07/29/2003US6599529 Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (NSAIDs)
07/29/2003US6599527 Preparation of pharmaceutical compositions
07/29/2003US6599522 For therapy and prophylaxis of hyperlipidemia (hypertriglyceridemia)
07/29/2003US6599499 Uses of diterpenoid triepoxides as an anti-proliferative agent
07/29/2003CA2269745C Improved treatment of migraine headache
07/29/2003CA2185036C Use of a non photosynthetic filamentous bacteria extract and composition containing the same
07/24/2003WO2003060521A2 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation
07/24/2003WO2003060468A2 Macrophage migration inhibitory factor (mif) promoter polymorphism in inflammatory disease
07/24/2003WO2003060150A2 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling
07/24/2003WO2003060148A2 Androgen regulated nucleic acid molecules and encoded proteins
07/24/2003WO2003060142A2 Compositions and methods for controlled release
07/24/2003WO2003060126A1 Rheumatoid arthritis disease sensitive gene, its protein, method and kit of judging the onset of rheumatoid arthritis using the same, and method and drugs for treating rheumatoid arthritis
07/24/2003WO2003060118A1 Iron-sulfur protein, protein-fad complex, electron transporter and method of measuring the inhibition of ferredotoxin activity
07/24/2003WO2003060106A1 Method and device for identifying substances capable of modulating adipocyte differentiation
07/24/2003WO2003060096A2 Assay for the detection of factors that modulate the expression of ingap
07/24/2003WO2003060034A1 Anion generating material and skin treating agent using the same
07/24/2003WO2003059951A2 Novel anti-igf-ir antibodies and uses thereof
07/24/2003WO2003059950A1 Ifnar2 mutants, their production and use
07/24/2003WO2003059927A1 Compositions and methods relating to endometrial specific genes and proteins
07/24/2003WO2003059886A1 Acyl sulfonamide derivative
07/24/2003WO2003059882A1 Phenoxy piperidines for treating diseases such as schizophrenia and depression
07/24/2003WO2003059880A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
07/24/2003WO2003059873A1 Potassium channel modulators
07/24/2003WO2003059871A1 N-alkylsulfonyl-substituted amide derivatives
07/24/2003WO2003059395A2 Antisense compounds directed against human csf-1
07/24/2003WO2003059378A2 Combined use of a glp-1 compound and another drug for treating dyslipidemia
07/24/2003WO2003059372A2 Combined use of a glp-1 compound and a modulator of diabetic late complications
07/24/2003WO2003059371A1 Anti-bacterial plant compositions
07/24/2003WO2003059367A1 A healthful chinese traditional medicinal preparation optimizing the brain
07/24/2003WO2003059361A1 Protection against the neurotoxicity of oxaliplatin through the administration of calcium and magnesium
07/24/2003WO2003059358A1 25-hydroxy vitamin d3 compositions
07/24/2003WO2003059357A1 Pregnane steroids for use in the treatment of cns disorders
07/24/2003WO2003059355A1 Quinazolinone compounds in combined modalities for improved cancer treatment
07/24/2003WO2003059354A2 Anti-angiogenesis combination therapies comprising pyridazine or pyridine derivatives
07/24/2003WO2003059353A1 Tyrosyl derivatives and their use as p2x7 receptor modulators
07/24/2003WO2003059349A1 Sedative non-benzodiazepine formulations
07/24/2003WO2003059347A1 Use of cox-2 inhibitors in combination with antiviral agents for the treatment of papilloma virus infections
07/24/2003WO2003059345A1 Pharmaceutical compositions comprising valsartan and nep inhibitors
07/24/2003WO2003059329A2 Polytartrate composition
07/24/2003WO2003059327A1 Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof
07/24/2003WO2003059323A2 Stable salts of o-acetylsalicylic acid containing basic amino acids ii
07/24/2003WO2003059296A2 Compositions comprising collagen and metalloprotease inhibitors
07/24/2003WO2003059294A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor
07/24/2003WO2003059293A2 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators
07/24/2003WO2003059291A2 Treatment of bone disorders with skeletal anabolic drugs
07/24/2003WO2003059288A2 Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds
07/24/2003WO2003059277A2 Methods and compositions for stimulating bone growth using inhibitors of microtubule assembly
07/24/2003WO2003059274A2 Vitamin formulation for cardiovascular health
07/24/2003WO2003059271A2 Treatment involving peroxisome proliferator-activated receptor-gamma agonist and cyclooxygenase-2 selective inhibitors
07/24/2003WO2003059269A2 Acridone inhibitors of impdh enzyme
07/24/2003WO2003059267A2 SELECTIVE 11β-HSD INHIBITORS AND METHODS FOR USE THEREOF
07/24/2003WO2003059266A2 Post-conditioning for the reduction of ischemic-reperfusion injury in the heart and other organs
07/24/2003WO2003059259A2 Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria
07/24/2003WO2003059253A2 Compositions and methods for altering glucose production
07/24/2003WO2003059148A2 Gene expression profiles in stomach cancer
07/24/2003WO2003048168A3 Trioxane derivatives as antimalaria or anticancer compounds
07/24/2003WO2003047577A3 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
07/24/2003WO2003045999A3 Human vanilloid receptor protein and polynucleotide sequence encoding same
07/24/2003WO2003045333A3 Treatment of hyperproliferative diseases using active vitamin d analogues
07/24/2003WO2003045332A3 Methods and compositions for treating lesions of the respiratory epithelium
07/24/2003WO2003043572A3 Methods and compositions related to irm compounds and toll-like receptor pathways
07/24/2003WO2003032909A3 Methods of treating skin with diphosphonate derivatives
07/24/2003WO2003018612A3 Extracellular messengers
07/24/2003WO2002099057A3 Sams modifiers of the p53 pathway and methods of use
07/24/2003WO2002078633A3 Agent for the treatment of bladder irritative symptoms accompanied by benign prostatic hyperplasia
07/24/2003WO2002078523A3 Agent for the treatment of overactive bladder
07/24/2003WO2002072104A3 Antihypertensive agent and cholesterol absorption inhibitor combination therapy
07/24/2003WO2002067988A3 Use of natural egfr inhibitors to prevent side effects due to retinoid therapy, soaps, and other stimuli that activate the epidermal growth receptor
07/24/2003WO2002060942A3 Protein modification and maintenance molecules
07/24/2003WO2002059323A3 Aminoacyl trna synthetases
07/24/2003WO2002052018A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
07/24/2003WO2002050278A3 Novel human secreted proteins and polynucleotides encoding the same
07/24/2003WO2002049575A3 Method and composition for the treatment of diabetic neuropathy
07/24/2003WO2002044417A3 Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
07/24/2003WO2002042272A3 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
07/24/2003WO2002036634A3 Gene regulation therapy involving ferritin
07/24/2003WO2002036100A9 Controlled release metformin compositions
07/24/2003WO2002019982A3 Cosmetic composition and method for reducing or preventing wrinkling
07/24/2003WO2002003979A3 Combination of 2-methoxyestradiol and an agent that increases intracellular superoxide anion
07/24/2003US20030140370 Fungal glyoxal oxidases
1 ... 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 ... 1151